1,407
Views
15
CrossRef citations to date
0
Altmetric
Reviews

Piperazine Based Substances of Abuse: A new Party Pills on Bulgarian Drug Market

&
Pages 652-655 | Published online: 15 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Daniel P. Katz, Mohammed Majrashi, Sindhu Ramesh, Manoj Govindarajulu, Dwipayan Bhattacharya, Subhrajit Bhattacharya, Aimen Shlghom, Chastity Bradford, Vishnu Suppiramaniam, Jack Deruiter, C. Randall Clark & Muralikrishnan Dhanasekaran. (2018) Comparing the dopaminergic neurotoxic effects of benzylpiperazine and benzoylpiperazine. Toxicology Mechanisms and Methods 28:3, pages 177-186.
Read now

Articles from other publishers (14)

Mohammed Almaghrabi, Younis Abiedalla, Murali Dhanasakaran, Jack DeRuiter & C. Randall Clark. (2022) GC–MS and GC–IR of regioisomeric 4-N-bromodimethoxybenzyl derivatives of 3-trifluoromethylphenylpiperazine. Forensic Chemistry 29, pages 100416.
Crossref
Paul Gee & Leo J. Schep. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 301 332 .
C.S. Johnson, C.R. Stansfield, V.R. Hassan, E. Kolbe, H.K. Partington, D.C. Kappatos & R.F. Somerville. (2020) The phenomenon of para-Fluorophenylpiperazine (pFPP) in combination with the synthetic cannabinoid AMB-FUBINACA in seized plant material in New Zealand. Forensic Science International 307, pages 110107.
Crossref
Mohammed Majrashi, Mohammed Almaghrabi, Maali Fadan, Ayaka Fujihashi, Wooseok Lee, Jack Deruiter, C. Randall Clark & Muralikrishnan Dhanasekaran. (2018) Dopaminergic neurotoxic effects of 3-TFMPP derivatives. Life Sciences 209, pages 357-369.
Crossref
Timothy Lau, Raquel LeBlanc & Sabra Botch-Jones. (2018) Stability of Synthetic Piperazines in Human Whole Blood. Journal of Analytical Toxicology 42:2, pages 88-98.
Crossref
D.P. Katz, J. Deruiter, D. Bhattacharya, M. Ahuja, S. Bhattacharya, C.R. Clark, V. Suppiramaniam & M. Dhanasekaran. (2016) Benzylpiperazine: “A messy drug”. Drug and Alcohol Dependence 164, pages 1-7.
Crossref
Marcelo Dutra Arbo, Rachel Picada Bulcão, Luciana Grazziotin Rossato, Elza Callegari, Lucas Henrique Cendron, Eduardo Rodrigues Cabrera, Marco Antonio de Freitas & Mirna Bainy Leal. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse 50 60 .
Nazia Parveen, Afzal Shah, Shahan Zeb Khan, Salah Ud-Din Khan, Usman Ali Rana, Farkhondeh Fathi, Aamir Hassan Shah, Muhammad Naeem Ashiq, Abdur Rauf, Rumana Qureshi, Zia-ur Rehman & Heinz-Bernhard Kraatz. (2014) Synthesis, Spectroscopic Characterization, pH Dependent Electrochemistry and Computational Studies of Piperazinic Compounds. Journal of The Electrochemical Society 162:1, pages H32-H39.
Crossref
Nicola M. Beckett, Sarah L. Cresswell, Darren I. Grice & James F. Carter. (2015) Isotopic profiling of seized benzylpiperazine and trifluoromethylphenylpiperazine tablets using δ13C and δ15N stable isotopes. Science & Justice 55:1, pages 51-56.
Crossref
Lucas R. Watterson, Elizabeth Watterson & Michael Foster Olive. (2013) Abuse liability of novel ‘legal high’ designer stimulants. Behavioural Pharmacology 24:5 and 6, pages 341-355.
Crossref
Janie Sheridan, Christine Yang Dong, Rachael Butler & Joanne Barnes. (2013) The impact of New Zealand's 2008 prohibition of piperazine-based party pills on young people's substance use: Results of a longitudinal, web-based study. International Journal of Drug Policy 24:5, pages 412-422.
Crossref
Márcia Sá Monteiro, Maria de Lourdes Bastos, Paula Guedes de Pinho & Márcia Carvalho. (2013) Update on 1-benzylpiperazine (BZP) party pills. Archives of Toxicology 87:6, pages 929-947.
Crossref
Paul Gee & Leo Schep. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances 179 209 .
Bruce M.Z. Cohen & Rachael Butler. (2011) BZP-party pills: A review of research on benzylpiperazine as a recreational drug. International Journal of Drug Policy 22:2, pages 95-101.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.